{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:28:38Z","timestamp":1773696518898,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000307","name":"British Federation of Women Graduates","doi-asserted-by":"publisher","award":["DHSabnis"],"award-info":[{"award-number":["DHSabnis"]}],"id":[{"id":"10.13039\/501100000307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000307","name":"British Federation of Women Graduates","doi-asserted-by":"publisher","award":["DHSabnis"],"award-info":[{"award-number":["DHSabnis"]}],"id":[{"id":"10.13039\/501100000307","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Nottingham Vice Chancellor&amp;#x2019;s Research Excellence Scholarship to D.H. Sabnis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Three of the hallmarks of poor prognosis in paediatric ependymoma are drug resistance, local invasion and recurrence. We hypothesised that these hallmarks were due to the presence of a sub-population of cancer stem cells expressing the multi-drug efflux transporter ABCB1. <jats:italic>ABCB1<\/jats:italic> gene expression was observed in 4 out of 5 paediatric ependymoma cell lines and increased in stem cell enriched neurospheres. Functional inhibition of ABCB1 using vardenafil or verapamil significantly (p\u2009\u2264\u20090.05\u20130.001) potentiated the response to three chemotherapeutic drugs (vincristine, etoposide and methotrexate). Both inhibitors were also able to significantly reduce migration (p\u2009\u2264\u20090.001) and invasion (p\u2009\u2264\u20090.001). We demonstrate that ABCB1 positive patients from an infant chemotherapy-led trial (CNS9204) had a shorter mean event free survival (EFS) (2.7 versus 8.6 years; p\u2009=\u20090.007 log-rank analysis) and overall survival (OS) (5.4 versus 12 years; p\u2009=\u20090.009 log-rank analysis). ABCB1 positivity also correlated with reduced event free survival in patients with incompletely resected tumours who received chemotherapy across CNS9204 and CNS9904 (a radiotherapy-led SIOP 1999-04 trial cohort; p\u2009=\u20090.03). ABCB1 is a predictive marker of chemotherapy response in ependymoma patients and vardenafil, currently used to treat paediatric pulmonary hypertension in children, could be repurposed to reduce chemoresistance, migration and invasion in paediatric ependymoma patients at non-toxic concentrations.<\/jats:p>","DOI":"10.1038\/s41598-019-46700-z","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T10:03:23Z","timestamp":1563271403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Durgagauri H.","family":"Sabnis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa C. D.","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Fen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah K.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Kilday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian D.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-1862","authenticated-orcid":false,"given":"Beth","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"issue":"Suppl 4","key":"46700_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom, Q. T. et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008\u20132012. Neuro Oncol 17(Suppl 4), iv1\u2013iv62, https:\/\/doi.org\/10.1093\/neuonc\/nov189 (2015).","journal-title":"Neuro Oncol"},{"key":"46700_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","volume":"15","author":"G Gatta","year":"2014","unstructured":"Gatta, G. et al. Childhood cancer survival in Europe 1999\u20132007: results of EUROCARE-5\u2013a population-based study. Lancet Oncol 15, 35\u201347, https:\/\/doi.org\/10.1016\/S1470-2045(13)70548-5 (2014).","journal-title":"Lancet Oncol"},{"key":"46700_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1470-2045(08)70342-5","volume":"10","author":"TE Merchant","year":"2009","unstructured":"Merchant, T. E. et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10, 258\u2013266 (2009).","journal-title":"Lancet Oncol"},{"key":"46700_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-5751-10-7","volume":"10","author":"DW Ellison","year":"2011","unstructured":"Ellison, D. W. et al. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10, 7, https:\/\/doi.org\/10.1186\/1477-5751-10-7 (2011).","journal-title":"J Negat Results Biomed"},{"key":"46700_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/1541-7786.MCR-08-0584","volume":"7","author":"JP Kilday","year":"2009","unstructured":"Kilday, J. P. et al. Pediatric ependymoma: biological perspectives. Mol Cancer Res 7, 765\u2013786, https:\/\/doi.org\/10.1158\/1541-7786.MCR-08-0584 (2009).","journal-title":"Mol Cancer Res"},{"key":"46700_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00401-012-0981-9","volume":"124","author":"C Godfraind","year":"2012","unstructured":"Godfraind, C. et al. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol 124, 247\u2013257, https:\/\/doi.org\/10.1007\/s00401-012-0981-9 (2012).","journal-title":"Acta Neuropathol"},{"key":"46700_CR7","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1158\/1078-0432.CCR-11-2489","volume":"18","author":"JP Kilday","year":"2012","unstructured":"Kilday, J. P. et al. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children\u2019s Cancer Leukaemia Group (CCLG), Societe Francaise d\u2019Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP). Clin Cancer Res 18, 2001\u20132011, https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2489 (2012).","journal-title":"Clin Cancer Res"},{"key":"46700_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"M Parker","year":"2014","unstructured":"Parker, M. et al. C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature 506, 451\u2013455, https:\/\/doi.org\/10.1038\/nature13109 (2014).","journal-title":"Nature"},{"key":"46700_CR9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler, K. W. et al. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell 27, 728\u2013743, https:\/\/doi.org\/10.1016\/j.ccell.2015.04.002 (2015).","journal-title":"Cancer Cell"},{"key":"46700_CR10","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1200\/JCO.2007.15.9970","volume":"26","author":"HM Conklin","year":"2008","unstructured":"Conklin, H. M., Li, C., Xiong, X., Ogg, R. J. & Merchant, T. E. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol 26, 3965\u20133970, https:\/\/doi.org\/10.1200\/JCO.2007.15.9970 (2008).","journal-title":"J Clin Oncol"},{"issue":"11","key":"46700_CR11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00381-009-0915-6","volume":"25","author":"Eric Bouffet","year":"2009","unstructured":"Bouffet, E., Tabori, U., Huang, A. & Bartels, U. Ependymoma: lessons from the past, prospects for the future. Childs Nerv Syst 25, 1383\u20131384; author reply 1385, https:\/\/doi.org\/10.1007\/s00381-009-0915-6 (2009).","journal-title":"Child's Nervous System"},{"key":"46700_CR12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1200\/JCO.2001.19.5.1288","volume":"19","author":"J Grill","year":"2001","unstructured":"Grill, J. et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19, 1288\u20131296, https:\/\/doi.org\/10.1200\/JCO.2001.19.5.1288 (2001).","journal-title":"J Clin Oncol"},{"key":"46700_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1470-2045(07)70208-5","volume":"8","author":"RG Grundy","year":"2007","unstructured":"Grundy, R. G. et al. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG\/SIOP prospective study. Lancet Oncol 8, 696\u2013705, https:\/\/doi.org\/10.1016\/S1470-2045(07)70208-5 (2007).","journal-title":"Lancet Oncol"},{"key":"46700_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ijrobp.2010.02.048","volume":"80","author":"M Massimino","year":"2011","unstructured":"Massimino, M. et al. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy. Int J Radiat Oncol Biol Phys 80, 807\u2013814, https:\/\/doi.org\/10.1016\/j.ijrobp.2010.02.048 (2011).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"46700_CR15","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","volume":"23","author":"JR Geyer","year":"2005","unstructured":"Geyer, J. R. et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children\u2019s Cancer Group. J Clin Oncol 23, 7621\u20137631, https:\/\/doi.org\/10.1200\/JCO.2005.09.095 (2005).","journal-title":"J Clin Oncol"},{"key":"46700_CR16","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.ejca.2009.03.018","volume":"45","author":"B Messahel","year":"2009","unstructured":"Messahel, B. et al. Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome. Eur J Cancer 45, 1815\u20131823, https:\/\/doi.org\/10.1016\/j.ejca.2009.03.018 (2009).","journal-title":"Eur J Cancer"},{"key":"46700_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000082295","volume":"40","author":"KM Akay","year":"2004","unstructured":"Akay, K. M. et al. Surgical outcomes of cerebellar tumors in children. Pediatr Neurosurg 40, 220\u2013225, https:\/\/doi.org\/10.1159\/000082295 (2004).","journal-title":"Pediatr Neurosurg"},{"key":"46700_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11060-011-0699-x","volume":"106","author":"JH Phi","year":"2012","unstructured":"Phi, J. H. et al. Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology. J Neurooncol 106, 619\u2013626, https:\/\/doi.org\/10.1007\/s11060-011-0699-x (2012).","journal-title":"J Neurooncol"},{"key":"46700_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cncr.21110","volume":"104","author":"AA Brandes","year":"2005","unstructured":"Brandes, A. A. et al. A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. Cancer 104, 143\u2013148, https:\/\/doi.org\/10.1002\/cncr.21110 (2005).","journal-title":"Cancer"},{"key":"46700_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ccr.2011.08.013","volume":"20","author":"JM Atkinson","year":"2011","unstructured":"Atkinson, J. M. et al. An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell 20, 384\u2013399, https:\/\/doi.org\/10.1016\/j.ccr.2011.08.013 (2011).","journal-title":"Cancer Cell"},{"key":"46700_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00401-012-0941-4","volume":"123","author":"K Wani","year":"2012","unstructured":"Wani, K. et al. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol 123, 727\u2013738, https:\/\/doi.org\/10.1007\/s00401-012-0941-4 (2012).","journal-title":"Acta Neuropathol"},{"key":"46700_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nat Rev Cancer 5, 275\u2013284 (2005).","journal-title":"Nat Rev Cancer"},{"key":"46700_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","volume":"21","author":"JA Magee","year":"2012","unstructured":"Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283\u2013296, https:\/\/doi.org\/10.1016\/j.ccr.2012.03.003 (2012).","journal-title":"Cancer Cell"},{"key":"46700_CR24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1750-3639.2012.00600.x","volume":"22","author":"T Milde","year":"2012","unstructured":"Milde, T. et al. Nestin expression identifies ependymoma patients with poor outcome. Brain Pathol 22, 848\u2013860, https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00600.x (2012).","journal-title":"Brain Pathol"},{"key":"46700_CR25","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1042\/BST20150137","volume":"43","author":"B Coyle","year":"2015","unstructured":"Coyle, B., Kessler, M., Sabnis, D. H. & Kerr, I. D. ABCB1 in children\u2019s brain tumours. Biochemical Society Transactions 43, 1018\u20131022 (2015).","journal-title":"Biochemical Society Transactions"},{"key":"46700_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/neuonc\/noq144","volume":"13","author":"D Hussein","year":"2011","unstructured":"Hussein, D. et al. Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair and etoposide extrusion. Neuro-Oncology 13, 70\u201383 (2011).","journal-title":"Neuro-Oncology"},{"key":"46700_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/neuonc\/nop056","volume":"12","author":"L Yu","year":"2010","unstructured":"Yu, L. et al. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol 12, 580\u2013594, https:\/\/doi.org\/10.1093\/neuonc\/nop056 (2010).","journal-title":"Neuro Oncol"},{"key":"46700_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00401-011-0866-3","volume":"122","author":"T Milde","year":"2011","unstructured":"Milde, T. et al. A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat. Acta Neuropathol 122, 637\u2013650, https:\/\/doi.org\/10.1007\/s00401-011-0866-3 (2011).","journal-title":"Acta Neuropathol"},{"key":"46700_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/2051-5960-2-57","volume":"2","author":"RT Othman","year":"2014","unstructured":"Othman, R. T. et al. Overcoming multiple drug resistance mechanisms in medulloblastoma. Acta Neuropathol Commun 2, 57, https:\/\/doi.org\/10.1186\/2051-5960-2-57 (2014).","journal-title":"Acta Neuropathol Commun"},{"key":"46700_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408, https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"46700_CR31","doi-asserted-by":"publisher","first-page":"e19329","DOI":"10.1371\/journal.pone.0019329","volume":"6","author":"PR Ding","year":"2011","unstructured":"Ding, P. R. et al. The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1\/P-glycoprotein transporter. PLoS One 6, e19329, https:\/\/doi.org\/10.1371\/journal.pone.0019329 (2011).","journal-title":"PLoS One"},{"key":"46700_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang, C. C., Park, A. Y. & Guan, J. L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2, 329\u2013333, https:\/\/doi.org\/10.1038\/nprot.2007.30 (2007).","journal-title":"Nat Protoc"},{"key":"46700_CR33","first-page":"2720","volume":"51","author":"RS Weinstein","year":"1991","unstructured":"Weinstein, R. S. et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51, 2720\u20132726 (1991).","journal-title":"Cancer Res"},{"key":"46700_CR34","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1073\/pnas.95.12.6924","volume":"95","author":"GJ Randolph","year":"1998","unstructured":"Randolph, G. J. et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci USA 95, 6924\u20136929 (1998).","journal-title":"Proc Natl Acad Sci USA"},{"key":"46700_CR35","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-04-3478","volume":"65","author":"KE Miletti-Gonzalez","year":"2005","unstructured":"Miletti-Gonzalez, K. E. et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res 65, 6660\u20136667, https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3478 (2005).","journal-title":"Cancer Res"},{"key":"46700_CR36","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.jid.5701082","volume":"128","author":"M Colone","year":"2008","unstructured":"Colone, M. et al. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol 128, 957\u2013971, https:\/\/doi.org\/10.1038\/sj.jid.5701082 (2008).","journal-title":"J Invest Dermatol"},{"key":"46700_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C. & Gottesman, M. M. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5, 219\u2013234, https:\/\/doi.org\/10.1038\/nrd1984 (2006).","journal-title":"Nat Rev Drug Discov"},{"key":"46700_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s10517-012-1525-y","volume":"152","author":"OA Patutina","year":"2012","unstructured":"Patutina, O. A. et al. Cyclophosphamide metabolite inducing apoptosis in RLS mouse lymphosarcoma cells is a substrate for P-glycoprotein. Bull Exp Biol Med 152, 348\u2013352 (2012).","journal-title":"Bull Exp Biol Med"},{"key":"46700_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","volume":"29","author":"TN Phoenix","year":"2016","unstructured":"Phoenix, T. N. et al. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. Cancer Cell 29, 508\u2013522, https:\/\/doi.org\/10.1016\/j.ccell.2016.03.002 (2016).","journal-title":"Cancer Cell"},{"key":"46700_CR40","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/rccm.201101-0093OC","volume":"183","author":"ZC Jing","year":"2011","unstructured":"Jing, Z. C. et al. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 183, 1723\u20131729, https:\/\/doi.org\/10.1164\/rccm.201101-0093OC (2011).","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46700-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46700-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46700-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:28:20Z","timestamp":1671276500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46700-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46700"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46700-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10290"}}